pathCast Lecture | The 2021 WHO Classification of Central Nervous System (CNS) Tumors: Update II - Glioneuronal Tumors

Duarte, CA US
January 18, 2022

Pathologic diagnosis of central nervous system (CNS) tumors plays an important role in deciding management options for the patients. The most recent (2021) WHO classification has addressed many issues in redefining diagnostic criteria, and molecular signatures of these tumors. This is going to have a significant impact on patient outcome. An update to address the recent changes in classification of the glioneuronal tumors is imperative. The purpose of this lecture is to update the pathologists about the recent updates in the WHO classification of CNS tumors.

Target Audience

Pathologists, neurosurgeons, oncologists, pathology fellows, and researchers.

Learning Objectives

  • Correctly diagnose and classify central nervous system (CNS) tumors.
  • Apply classifications to future research.
  • Participate in multidisciplinary approach to management of CNS glioneuronal tumors.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
     
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | The 2021 WHO Classification of Central Nervous System (CNS) Tumors: Update II - Glioneuronal Tumors for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
01/18/2022
Activity expires: 
01/19/2022
Event starts: 
01/18/2022 - 9:00am PST
Event ends: 
01/18/2022 - 10:00am PST
Add to calendar: 
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Fausto Rodriguez, MD   Professor and Chief of Neuropathology, UCLA David Geffen School of Medicine

Dr. Rodriguez has indicated that he does not have anything to disclose.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | The 2021 WHO Classification of Central Nervous System (CNS) Tumors: Update II - Glioneuronal Tumors for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.